Study Results from Capital Medical University Update Understanding of Alcoholic Fatty Liver (Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver...).

A recent study conducted by Capital Medical University in Beijing, China, aimed to understand the impact of the diagnosis of metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD) on liver transplant recipients with hepatocellular carcinoma (HCC). The study found that the diagnosis of MAFLD was more strongly associated with metabolic abnormalities than the diagnosis of NAFLD. Factors such as tumor size, microvascular invasion, lack of tumor capsule, post-transplant MAFLD, and decreased post-transplant lymphocyte percentage were identified as risk factors for HCC recurrence. This research provides valuable insights into the prognosis and management of liver transplant recipients with HCC. [Extracted from the article]